<div id="readability-page-1"><p>Cushman &amp; Wakefield PLC (NYSE:CWK - Get Free Report) has been assigned an average rating of &#34;Hold&#34; from the eleven research firms that are presently  covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold rating and five have issued  a buy rating on  the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $17.4444.</p><div><p><span></span><span>Get <strong>Cushman &amp; Wakefield</strong> alerts:</span></p></div><ul><li>Real Estate Stock Signals a Boom in Manufacturing Activity</li></ul><p>A number of research firms have recently issued reports on CWK. Barclays assumed coverage on Cushman &amp; Wakefield in a research report on Tuesday, December 2nd. They issued an &#34;equal weight&#34; rating and a $18.00 price objective for the company. Wall Street Zen downgraded Cushman &amp; Wakefield from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a report on Saturday. JPMorgan Chase &amp; Co. lifted their price objective on shares of Cushman &amp; Wakefield from $13.00 to $20.00 and gave the stock a &#34;neutral&#34; rating in a research report on Tuesday, August 26th. Citizens Jmp increased their price objective on shares of Cushman &amp; Wakefield from $16.00 to $19.00 and gave the company a &#34;market outperform&#34; rating in a research report on Monday, November 3rd. Finally, UBS Group raised their target price on shares of Cushman &amp; Wakefield from $12.00 to $17.00 and gave the stock a &#34;neutral&#34; rating in a research note on Friday, October 10th.</p><p><b>Get Our Latest Report on Cushman &amp; Wakefield</b></p><h2>Institutional Investors Weigh In On Cushman &amp; Wakefield</h2><ul><li>Renewed Analyst Sentiment for CBRE Group Stock: Buy the Dip?</li></ul><p>Institutional investors have recently made changes to their positions in the company. Frontier Capital Management Co. LLC bought a new position in  Cushman &amp; Wakefield during the second quarter worth about $51,764,000.  Vaughan Nelson Investment Management L.P. boosted its holdings in  Cushman &amp; Wakefield by 46.2% in the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 12,156,514 shares of the company's stock valued at $134,573,000 after purchasing an additional 3,842,859 shares during the period.  Channing Capital Management LLC bought a new stake in  Cushman &amp; Wakefield in the 3rd quarter valued at about $55,665,000.  Balyasny Asset Management L.P. grew its position in shares of  Cushman &amp; Wakefield by 128.6% during the 2nd quarter. Balyasny Asset Management L.P. now owns 2,879,485 shares of the company's stock worth $31,876,000 after purchasing an additional 1,620,143 shares in the last quarter.  Finally, Millennium Management LLC increased its holdings in shares of  Cushman &amp; Wakefield by 374.6% during the third quarter. Millennium Management LLC now owns 1,716,049 shares of the company's stock worth $27,320,000 after purchasing an additional 1,354,476 shares during the period. Institutional investors own  95.56% of the company's stock. </p><h2>Cushman &amp; Wakefield Stock Up 0.9%</h2><p>Cushman &amp; Wakefield stock opened at $15.44 on Wednesday. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.07 and a quick ratio of 1.07. The company's 50-day moving average is $15.82 and its 200-day moving average is $14.23. The firm has a market capitalization of $3.58 billion, a PE ratio of 16.08 and a beta of 1.46. Cushman &amp; Wakefield has a fifty-two week low of $7.64 and a fifty-two week high of $17.33. </p><p>Cushman &amp; Wakefield (NYSE:CWK - Get Free Report) last issued its earnings results on Thursday, October 30th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.01. The business had revenue of $2.61 billion during the quarter, compared to the consensus estimate of $2.51 billion. Cushman &amp; Wakefield had a net margin of 2.23% and a return on equity of 14.69%. Cushman &amp; Wakefield's revenue was up 11.2% on a year-over-year basis. During the same period last year, the business posted $0.23 EPS. Cushman &amp; Wakefield has set its FY 2025 guidance at 1.180-1.230 EPS.  Sell-side analysts anticipate that  Cushman &amp; Wakefield will post 1.2 earnings per share for the current year. </p><h2>Cushman &amp; Wakefield Company Profile</h2> (Get Free Report)<p>Cushman &amp; Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Cushman &amp; Wakefield</li><li>Financial Services Stocks Investing</li><li>Why Taiwan Semiconductor's 6.5% Dip Could Be a Smart Buy</li><li>How to Calculate Options Profits</li><li>RTX Surges to Record Highs as Defense Orders Explode</li><li>Differences Between Momentum Investing and Long Term Investing </li><li>Smart Money Is Buying Auto Suppliers, Not Car Brands</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNXSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNXSw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Cushman &amp; Wakefield Right Now?</h2><p>Before you consider Cushman &amp; Wakefield, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cushman &amp; Wakefield wasn't on the list.</p><p>While Cushman &amp; Wakefield currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Cushman & Wakefield PLC (NYSE:CWK) has received a consensus "Hold" rating from eleven research firms. The average 12-month price target is $17.44. Recent analyst actions include Barclays' "equal weight" rating with an $18 target, and JPMorgan's "neutral" rating with a $20 target. Institutional investors have significantly increased their holdings. The company reported Q3 earnings of $0.29 per share, beating estimates, with revenue up 11.2% year-over-year.</p>

Cushman & Wakefield PLC (NYSE:CWK) Receives Consensus Rating of "Hold" from Analysts